Stemline Therapeutics INC
SEC CIK 1264587 · STML · last insider filing 2020-06-10
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Zuerblis Kenneth J | Director | filed 2013 - 2020 |
| Bentsur RON | Director | filed 2013 - 2020 |
| Forman Alan S | Director | filed 2015 - 2020 |
| Bergstein Ivan | Director · Chief Executive Officer | filed 2013 - 2020 |
| Cline Darren S | Director | filed 2018 - 2020 |
| Hume Daniel | Director | filed 2018 - 2020 |
| Sard Mark | Director | filed 2018 - 2020 |
| Dobmeier Eric | Director | filed 2013 - 2017 |
| Buchi J Kevin | Director | filed 2013 - 2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Gionco David | Chief Accounting Officer | filed 2014 - 2020 |
| Hoberman Kenneth | Chief Operating Officer | filed 2013 - 2020 |
| Francomano Robert | Chief Commercial Officer | filed 2019 - 2020 |
| Rowinsky Eric K | EVP, Chief Med. Off., Head R&D | filed 2013 - 2015 |
| Hall Stephen P | VP Finance; CAO; PFO | filed 2013 - 2013 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.